SCHEMBL4059100

SCHEMBL4059100

Cc1cc(Cc2ccc(O)cc2O)c(O)c(Cc2cc(C)cc(Cc3ccc(O)cc3O)c2O)c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.61
TYR P14679 6/20 0.52
ALOX5 P09917 3/20 0.52
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
MEN1 O00255 2/20 0.49
MAPT P10636 2/20 0.49
KMT2A Q03164 2/20 0.49
HSPA5 P11021 1/20 0.47
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4004589 1.00 AMY1A (0.61) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL4055159 1.00 AMY1A (0.61) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL30703618 1.00 AMY1A (0.61) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL18174860 0.95 AMY1A (0.66) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL14462755 0.93 AMY1A (0.54) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL21096824 0.92 AMY1A (0.57) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL22500133 0.91 AMY1A (0.51) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL17340631 0.89 AMY1A (0.50) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL4062078 0.87 ALOX5 (0.49) AMY1ATYRALOX5CYP2C9CYP2C19
SCHEMBL19621170 0.86 AMY1A (0.75) AMY1AALOX5CYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131238-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, PROTECTIVE FILM, INSULATING FILM, AND SEMICONDUCTOR DEVICE AND DISPLAY DEVICE USING THE CURED FILM Sumitomo Bakelite Co., Ltd. (JP) 2009-12-09 EP disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM AMY1A 2387/4885TYR 1522/4885ALOX5 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.